Abstract
Background: Hematological abnormalities are known to be independent predictors of morbidity and mortality in HIV-infected patients. The current study was conducted to evaluate the hemoglobin levels and CD4 count at the time of initiation of highly active antiretroviral therapy (HAART) of newly diagnosed HIV/AIDS patients attending ART centre at Goa Medical College.Methods: A hospital based observational retrospective study was carried out in Department of Medicine of Goa Medical College in collaboration with ART centre from October 2015 to January 2016. Patient’s relevant data about the infection was collected from patient’s treatment record card at the ART centre using preformed questionnaire.Results: The prevalence of anaemia in study participants was 66.35%. The prevalence of severe anaemia and mild-moderate anaemia was 9% and 57.3% respectively, while 33.65% of participants were not anaemic. Significant difference was observed in the prevalence of anaemia among immune deficient male participants (CD4 count <500 cells/mm3) and participants with no significant immune deficiency (CD4 count ≥500 cells /mm3) (77.5% versus 50%). Significant difference was also seen in the prevalence of anaemia among immune deficient female participants (CD4 count <500 cells/mm3) and participants with no significant immune deficiency (CD4 count ≥500 cells /mm3) (93.5% versus 56%).Conclusions: The current study revealed high prevalence of anemia in HIV patients prior to the initiation of ART in both males as well as females. Mild to moderate anemia was predominant in the study participants than severe anemia. There was significant difference observed in the prevalence of anemia among immune deficient population and participants with normal CD4 count. Prompt diagnosis of anaemia, identification of the underlying cause of anaemia in HIV patients as well as the implementation of appropriate treatment is essential.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.